Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David V Glidden

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Genetic Epidemiology|October 18, 2002
Rejoinder on "ascertainment adjustment in complex diseases"David V Glidden
Biometrics|June 20, 2002
Robust inference for event probabilities with non-Markov event dataDavid V Glidden
Nature|October 19, 2012
HIV: Design by trialDavid V Glidden
Current Opinion in HIV and AIDS|October 1, 2019
Statistical approaches to accelerate the development of long-acting antiretrovirals for HIV pre-exposure prophylaxisDavid V Glidden
Statistical Communications in Infectious Diseases|September 10, 2019
Advancing Novel PrEP Products - Alternatives to Non-InferiorityDavid V Glidden
Statistics in Medicine|January 30, 2004
Modelling clustered survival data from multicentre clinical trialsDavid V Glidden, Eric Vittinghoff
Lancet (London, England)|April 27, 2016
HIV moments and pre-exposure prophylaxisRobert M Grant, David V Glidden
Genetic Epidemiology|October 18, 2002
Ascertainment adjustment in complex diseasesDavid V Glidden, Kung-Yee Liang
Current Opinion in HIV and AIDS|November 7, 2015
Statistical issues in trials of preexposure prophylaxisDavid T Dunn, David V Glidden
Respiratory Care|January 24, 2024
Reply to: Letter Regarding Time to Extubation Among ARDS Subjects With and Without COVID-19 Pneumonia ManuscriptGregory D Burns, David V Glidden
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Genetic Epidemiology|October 18, 2002
Rejoinder on "ascertainment adjustment in complex diseases"David V Glidden
Biometrics|June 20, 2002
Robust inference for event probabilities with non-Markov event dataDavid V Glidden
Nature|October 19, 2012
HIV: Design by trialDavid V Glidden
Current Opinion in HIV and AIDS|October 1, 2019
Statistical approaches to accelerate the development of long-acting antiretrovirals for HIV pre-exposure prophylaxisDavid V Glidden
Statistical Communications in Infectious Diseases|September 10, 2019
Advancing Novel PrEP Products - Alternatives to Non-InferiorityDavid V Glidden
Statistics in Medicine|January 30, 2004
Modelling clustered survival data from multicentre clinical trialsDavid V Glidden, Eric Vittinghoff
Lancet (London, England)|April 27, 2016
HIV moments and pre-exposure prophylaxisRobert M Grant, David V Glidden
Genetic Epidemiology|October 18, 2002
Ascertainment adjustment in complex diseasesDavid V Glidden, Kung-Yee Liang
Current Opinion in HIV and AIDS|November 7, 2015
Statistical issues in trials of preexposure prophylaxisDavid T Dunn, David V Glidden
Respiratory Care|January 24, 2024
Reply to: Letter Regarding Time to Extubation Among ARDS Subjects With and Without COVID-19 Pneumonia ManuscriptGregory D Burns, David V Glidden
Pageof 27